Skip to main content
NCBI home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2008 Jun 3;9(4):215–220. doi: 10.1007/s10194-008-0043-9

Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate

Ingelise Christiansen 1, Helle K Iversen 1, Jes Olesen 1, Peer Tfelt-Hansen 1,✉
PMCID: PMC3451949  PMID: 18521538

Abstract

Long-term exposure to organic nitrates influences different sections of the vascular bed heterogeneously. Continuous dosage of nitrates leads to the development of tolerance both to the vascular effects and to the unwanted adverse effect, headache. Human data on the development of tolerance in different cranial arteries over more than 24 h are lacking. We compared the vascular changes of the middle cerebral, superficial temporal and radial arteries during oral administration of isosorbide-5-mononitrate (5-ISMN) 30 mg three times daily for 7 days in 11 healthy subjects in a double-blind, randomised, placebo controlled cross-over design. Blood velocity in the middle cerebral artery was measured with transcranial Doppler and the diameters of the temporal and radial arteries were measured with high frequency ultrasound. Headache recordings were compared to the observed vascular changes over time. Tolerance was complete within 24 h in the middle cerebral artery whilst in the superficial temporal and the radial arteries, tolerance was only partial and developed much more slowly, i.e. after 7 days correlating with the disappearance of NO-induced headache. The present study thus demonstrated the important differences in the time profiles of appearance of nitrate tolerance in arteries of different vascular beds in man. If vasodilatation is the cause of NO-induced headache the results point to extracerebral arteries as the locus of nociception. Due to a variety of other possible pain-inducing effects of nitric oxide our results do not exclude cerebral arteries.

Keywords: Nitrate tolerance, Nitric oxide, Arteries, Headache, Isosorbide-5-mononitrate

Full Text

The Full Text of this article is available as a PDF (202.6 KB).

Acknowledgments

The study was supported by the University of Copenhagen, the Danish Headache Society and the Lundbeck Foundation via the Lundbeck Foundation Center for Neurovascular Research (LUCENS). We are indebted to Ms Bente Leisner and Ms Kirsten Enghave for excellent and careful technical assistance in the laboratory.

Conflict of interest

None.

References

  • 1.Ignarro LJ, Lipton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA. Mechanisms of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218:739–749. [PubMed] [Google Scholar]
  • 2.Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest. 1991;21:361–374. doi: 10.1111/j.1365-2362.1991.tb01383.x. [DOI] [PubMed] [Google Scholar]
  • 3.Iversen HK, Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia. 1996;16:412–418. doi: 10.1046/j.1468-2982.1996.1606412.x. [DOI] [PubMed] [Google Scholar]
  • 4.Iversen HK, Nielsen TH, Garre K, Tfelt-Hansen P, Olesen J. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol. 1992;42:31–35. doi: 10.1007/BF00314916. [DOI] [PubMed] [Google Scholar]
  • 5.Olesen J, Thomsen LL, Iversen HK. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994;15:149–153. doi: 10.1016/0165-6147(94)90075-2. [DOI] [PubMed] [Google Scholar]
  • 6.Fletcher A, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomized controlled trial of transdermal glyceryl trinitrate against placebo. Lancet. 1988;2(8601):4–8. doi: 10.1016/S0140-6736(88)92942-X. [DOI] [PubMed] [Google Scholar]
  • 7.Christiansen I, Iversen HK, Olesen J. Headache characteristics during the development of tolerance to nitrites. Pathophysiological implications. Cephalalgia. 2002;20:437–444. doi: 10.1046/j.1468-2982.2000.00064.x. [DOI] [PubMed] [Google Scholar]
  • 8.Aaslid R, Markwalder TM, Nomes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769–774. doi: 10.3171/jns.1982.57.6.0769. [DOI] [PubMed] [Google Scholar]
  • 9.Thomsen LL, Iversen HK. Experimental and biological variation of three-dimensional transcranial Doppler measurements. J Appl Physiol. 1993;75:2805–2810. doi: 10.1152/jappl.1993.75.6.2805. [DOI] [PubMed] [Google Scholar]
  • 10.Nielsen TH, Iversen HK, Tfelt-Hansen P, Olesen J. Small arteries can be accurately studied in-vivo, using high frequency ultrasound. Ultrasound Med Biol. 1993;19:717–725. doi: 10.1016/0301-5629(93)90089-7. [DOI] [PubMed] [Google Scholar]
  • 11.Nielsen TH, Iversen HK, Tfelt-Hansen P. Determination of the luminal diameter of the radial artery in man by high frequency ultrasound: a methodological study. Ultrasound Med Biol. 1990;16:789–791. doi: 10.1016/0301-5629(90)90042-B. [DOI] [PubMed] [Google Scholar]
  • 12.Matthews JNS, Altman DG, Cambell MJ, Royston P. Analysis of serial measurements in medical research. MBJ. 1990;300:230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Münzel T, Daiber A, Mülsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005;97:618–628. doi: 10.1161/01.RES.0000184694.03262.6d. [DOI] [PubMed] [Google Scholar]
  • 14.Taylor T, Chasseaud LF, Major R, Doyle E, Darragh A. Isosorbide 5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos. 1981;2:255–263. doi: 10.1002/bdd.2510020306. [DOI] [PubMed] [Google Scholar]
  • 15.Major RM, Taylor T, Chasseaud LF, Darragh A, Lambe RF. Isosorbide 5-mononitrate kinetics. Clin Pharmacol Ther. 1984;35:653–659. doi: 10.1038/clpt.1984.90. [DOI] [PubMed] [Google Scholar]
  • 16.Wagner F, Siefert F, Trenk D, Jänchen E. Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate. Eur J Clin Pharmacol. 1990;38(Suppl 1):S53–S59. doi: 10.1007/BF01417565. [DOI] [PubMed] [Google Scholar]
  • 17.Dahl A, Russell D, Nyberg-Hansen R, Rootwell K. Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke. 1989;20:173–176. doi: 10.1161/01.str.20.12.1733. [DOI] [PubMed] [Google Scholar]
  • 18.Iversen HK, Friberg L, Holm S, Tfelt-hansen P (2008) Intracranial hemodynamics during intravenous infusion of nitroglycerin. J Headache Pain (in press) [DOI] [PMC free article] [PubMed]
  • 19.White RP, Deane C, Hindley C, Bloomfield PM, Cunningham VJ, Vallance P, et al. The effect of the nitric oxide donor glyceryl trinitrate on global and regional cerebral blood flow in man. J Neurol Sci. 2000;178:23–28. doi: 10.1016/S0022-510X(00)00357-9. [DOI] [PubMed] [Google Scholar]
  • 20.Bednarczyk EM, Wack DS, Kassab MY, Burch K, Trinidad K, Haka M, Gona J. Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emision tomography and transcranial Doppler. Cephalalgia. 2002;22:749–757. doi: 10.1046/j.1468-2982.2002.00440.x. [DOI] [PubMed] [Google Scholar]
  • 21.Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 1991;338:13–17. doi: 10.1016/0140-6736(91)90005-A. [DOI] [PubMed] [Google Scholar]
  • 22.Thomsen LL, Iversen HK, Brinck TA, Olesen J. Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia. 1993;13:395–399. doi: 10.1046/j.1468-2982.1993.1306395.x. [DOI] [PubMed] [Google Scholar]
  • 23.Schmetterer L, Woltz M, Krejcy K, Graselli U, Findl O, Eichler HG, Singer EA. Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. Clin Pharmacol Ther. 1996;60:199–205. doi: 10.1016/S0009-9236(96)90136-8. [DOI] [PubMed] [Google Scholar]
  • 24.Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the delopment of tolerance and evidence: a human in vivo study. J Am Coll Cardiol. 2001;38:854–859. doi: 10.1016/S0735-1097(01)01414-0. [DOI] [PubMed] [Google Scholar]
  • 25.Iversen HK, Nielsen TH, Tfelt-Hansen P, Olesen J. Lack of tolerance of headache and radial artery diameter during a 7 hour intravenous infusion of nitroglycerin. Eur J Clin Pharmacol. 1993;44:47–50. doi: 10.1007/BF00315279. [DOI] [PubMed] [Google Scholar]
  • 26.Boesgaard S, Iversen H, Wroblewski H, Poulsen HE, Frandsen H, Kastrup J, Aldershvile J. Altered peripheral vasodilatory profile of nitroglycerin during long-term infusion of N-acetylcystein. J Am Coll Cardiol. 1994;23:163–169. doi: 10.1016/0735-1097(94)90515-0. [DOI] [PubMed] [Google Scholar]
  • 27.Jeserich M, Münzel T, Pape L, Fischer C, Drexler H, Just H. Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease. J Am Coll Cardiol. 1995;26:50–56. doi: 10.1016/0735-1097(95)00155-S. [DOI] [PubMed] [Google Scholar]
  • 28.Zhang LM, Castresana MR, Newman WH. Tolerance to nitroglycerin in vascular smooth muscle cells: recovery and cross-tolerance to sodium nitroprusside. Anesth Analg. 1994;78:1053–1059. doi: 10.1213/00000539-199406000-00004. [DOI] [PubMed] [Google Scholar]
  • 29.Tao H, Zhang LM, Castresana MR, Newman WH, Shillcutt SD. Response of cultured cerebral artery smooth muscle cells to the nitric oxide vasodilator, nitroglycerin and sodium nitroprusside. J Neurosurg Anesth. 1997;1:58–64. doi: 10.1097/00008506-199701000-00013. [DOI] [PubMed] [Google Scholar]
  • 30.Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance and strategies for prevention. Ann Int Med. 1991;114:667–677. doi: 10.7326/0003-4819-114-8-667. [DOI] [PubMed] [Google Scholar]
  • 31.Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism of tolerance and cross tolerance. J Clin Invest. 1995;95:187–194. doi: 10.1172/JCI117637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Münzel T, Giaid A, Kurz S, Stewart D, Harrison D. Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Natl Acad Sci USA. 1995;92:5244–5248. doi: 10.1073/pnas.92.11.5244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Szöcs K, Lasseque B, Wenzel P, Wendt M, Daiber A, Oelze M, Meinertz T, Münzel T, Baldus S. Increased superoxide production in nitrate tolerance is associated with NAD(P) H oxidase and aldehyde dehydrogenase 2 downregulation. J Mol Cell Cardiol. 2007;42:1111–1118. doi: 10.1016/j.yjmcc.2007.03.904. [DOI] [PubMed] [Google Scholar]
  • 34.Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336–2345. doi: 10.1161/01.cir.84.6.2336. [DOI] [PubMed] [Google Scholar]
  • 35.Chen YR, Nie SD, Shan W, Jiang DJ, Shi RZ, Zhou Z, et al. Decrease in endogenous CGRP release in nitroglycerin tolerance: role of ALDH-2. Eur J Pharmacol. 2007;571:44–50. doi: 10.1016/j.ejphar.2007.05.042. [DOI] [PubMed] [Google Scholar]
  • 36.Daiber A, Oelze M, Coldeway M, Bachsmid M, Wenzel P, Sydow K, et al. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol with other organic nitrates. Mol Pharmacol. 2004;66:1372–1382. doi: 10.1124/mol.104.002600. [DOI] [PubMed] [Google Scholar]
  • 37.Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest. 2004;113:482–489. doi: 10.1172/JCI19267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hink U, Daiber A, Kayhan N, Trischler J, Kattz C, Oelze M, et al. Oxidative inhibition of mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol. 2007;50:2226–2232. doi: 10.1016/j.jacc.2007.08.031. [DOI] [PubMed] [Google Scholar]
  • 39.Schoonman GG, Bakker D, Schmitz N, Geest RJ, Grond J, Ferrari MD, Buchem MA. Magnetic resonance angiography of the human meningeal artery: implications for migraine. J Magn Reson Imaging. 2006;24:918–921. doi: 10.1002/jmri.20708. [DOI] [PubMed] [Google Scholar]
  • 40.Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildefanil without changes in middle cerebral artery diameter. Brain. 2003;126:241–247. doi: 10.1093/brain/awg009. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES